Olema Pharmaceuticals, Inc(NASDAQ:OLMA) 
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clini...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 3.23
H 3.35
L 3.18
C 3.25
V 1,237,243
10EMA 3.25
20EMA 3.25
60EMA 3.25
120EMA 3.25
250EMA 3.25